Skip to main content
    P

    Processa Pharmaceuticals Inc (PCSA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.73
    +0.01 (+0.58%)

    Market Cap: $4.81M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Processa Pharmaceuticals Inc (PCSA) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Processa Pharmaceuticals (PCSA) has a latest price of $1.73 on Nov 17, 2026, 80.5% below its 52-week high of $8.88. Its price fell 76.9% over the past 12 months. The month-end price fell 99.3% since Oct 2017, a compound annual decline of 42.8%.

    Price Chart

    From Oct 2017 to Oct 2026, its highest month-end close was $9,000.00 in Dec 2019 and its lowest $1.64 in Sep 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart PCSA with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PCSA.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 19.5%, and over 6 months it fell 33.7%. The month-end price fell 98.9% over the 3 years through Oct 2026, a compound annual decline of 77.9%.

    PeriodChange
    1 month0.0%
    3 months-19.5%
    6 months-33.7%
    12 months-76.9%
    12 months, with dividends-76.9%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-98.9%-77.9%
    5 years-99.9%-77.7%
    Since Oct 2017-99.3%-42.8%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2019, when the price rose 400.0%, and its weakest was 2025, when it fell 87.0%.

    YearCloseChange
    2026 through Oct 2026$1.89-34.4%
    2025$2.88-87.0%
    2024$22.09-86.8%
    2023$167.30-69.6%
    2022$550.00-77.6%
    2021$2,450.00-25.7%
    2020$3,297.50-63.4%
    2019$9,000.00+400.0%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 3.6% below its 50-day average of $1.79 and 24.2% below its 200-day average of $2.28.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$1.73
    52-week high$8.88-80.5%
    52-week low$1.04+66.2%
    50-day average$1.79-3.6%
    200-day average$2.28-24.2%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 99.7%.

    MeasureValue
    1-year beta1.15
    Largest fall, 1 year-82.4%
    Largest fall, 3 years-99.7%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About PCSA

    What is PCSA's 1-year price change?

    Processa Pharmaceuticals's price fell 76.9% over the past 12 months. With dividends included, the 12-month total return was -76.9%.

    What is PCSA's 5-year price change?

    Processa Pharmaceuticals's month-end price fell 99.9% over the 5 years through Oct 2026, a compound annual decline of 77.7%. These figures leave out dividends.

    What is PCSA's 52-week high and low?

    Processa Pharmaceuticals's 52-week high is $8.88 and its 52-week low is $1.04. Its latest price of $1.73 on Nov 17, 2026 is 80.5% below the high.

    What is PCSA's beta?

    Processa Pharmaceuticals's 1-year beta against the S&P 500 is 1.15, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 82.4%.

    Is the PCSA chart free?

    Yes. Advanced Charting for PCSA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.